Dupilumab significantly reduces exacerbations and improves lung function in COPD patients with elevated eosinophil counts, confirming the efficacy of targeting type 2 inflammation.
Dupilumab shows promise in cutting COPD flare-ups and boosting lung function
- Post author:
- Post published:
- Post category:uncategorized